Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 3836 participants.
Also called NCT07644234
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 3,836 participants
- Registry
-
NCT07644234
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07644234. Randomized; no masking; primary purpose prevention. Start 2026-06 (anticipated); primary completion 2028-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke
- Acronym
- PATH STROKE D
- Condition
- Ischemic Stroke
- Condition
- Transient Ischemic Attack
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Aspirin
- Lead sponsor
- Sichuan Provincial People's Hospital
Record details
- Record id
cardio:ct-nct07644234- Content hash
3c79289e70c76aaec854fc2ebd043361877c7cc0a2f4b2af8ec22d23377607e9